News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
210,456 Results
Type
Article (19321)
Company Profile (37)
Press Release (191098)
Section
Business (56750)
Career Advice (444)
Deals (8465)
Drug Delivery (28)
Drug Development (25983)
Employer Resources (35)
FDA (4473)
Job Trends (5009)
News (95033)
Policy (7572)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Standard (1)
2026 Genetown Elite (1)
Academia (1881)
Academic (1)
Accelerated approval (1)
Adcomms (12)
Allergies (21)
Alliances (17196)
ALS (41)
Alzheimer's disease (589)
Antibody-drug conjugate (ADC) (30)
Approvals (4517)
Artificial intelligence (105)
Autoimmune disease (4)
Automation (6)
Bankruptcy (67)
Best Places to Work (4181)
BIOSECURE Act (14)
Biosimilars (27)
Biotechnology (28)
Bladder cancer (36)
Brain cancer (16)
Breast cancer (122)
Cancer (961)
Cardiovascular disease (69)
Career advice (394)
Career pathing (13)
CAR-T (59)
Cell therapy (173)
Cervical cancer (15)
Clinical research (20698)
Collaboration (372)
Compensation (159)
Complete response letters (5)
COVID-19 (1219)
CRISPR (21)
C-suite (92)
Cystic fibrosis (43)
Data (939)
Decentralized trials (2)
Denatured (3)
Depression (11)
Diabetes (79)
Diagnostics (2539)
Digital health (7)
Diversity (3)
Diversity, equity & inclusion (10)
Drug discovery (44)
Drug pricing (26)
Drug shortages (2)
Duchenne muscular dystrophy (45)
Earnings (16354)
Editorial (7)
Employer branding (6)
Employer resources (29)
Events (29694)
Executive appointments (257)
FDA (4970)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (348)
Gene editing (42)
Generative AI (12)
Gene therapy (137)
GLP-1 (156)
Government (1431)
Guidances (27)
Healthcare (6464)
Huntington's disease (6)
IgA nephropathy (5)
Immunology and inflammation (23)
Indications (11)
Infectious disease (1273)
Inflammatory bowel disease (46)
Inflation Reduction Act (3)
Influenza (23)
Intellectual property (32)
Interviews (55)
IPO (4029)
IRA (16)
Job creations (1133)
Job search strategy (355)
Kidney cancer (7)
Labor market (22)
Layoffs (120)
Leadership (4)
Legal (1330)
Liver cancer (26)
Lung cancer (146)
Lymphoma (67)
Machine learning (2)
Management (11)
Manufacturing (88)
MASH (20)
Medical device (4157)
Medtech (4157)
Mergers & acquisitions (4673)
Metabolic disorders (160)
Multiple sclerosis (29)
NASH (4)
Neurodegenerative disease (20)
Neuropsychiatric disorders (3)
Neuroscience (782)
NextGen: Class of 2025 (2251)
Non-profit (2097)
Northern California (1052)
Now hiring (13)
Obesity (65)
Opinion (73)
Ovarian cancer (39)
Pain (28)
Pancreatic cancer (40)
Parkinson's disease (48)
Partnered (13)
Patents (60)
Patient recruitment (41)
Peanut (13)
People (19888)
Pharmaceutical (11)
Pharmacy benefit managers (1)
Phase I (6929)
Phase II (9488)
Phase III (6580)
Pipeline (459)
Podcasts (9)
Policy (53)
Postmarket research (679)
Preclinical (3044)
Press Release (36)
Prostate cancer (45)
Psychedelics (12)
Radiopharmaceuticals (99)
Rare diseases (153)
Real estate (1826)
Recruiting (14)
Regulatory (5533)
Reports (26)
Research institute (1963)
Resumes & cover letters (47)
Rett syndrome (1)
RNA editing (2)
RSV (12)
Schizophrenia (23)
Series A (56)
Series B (27)
Service/supplier (4)
Sickle cell disease (26)
Southern California (1009)
Special edition (14)
Spinal muscular atrophy (33)
Sponsored (6)
Startups (1458)
Stomach cancer (4)
Supply chain (18)
The Weekly (6)
United States (9323)
Vaccines (276)
Venture capitalists (12)
Webinars (4)
Weight loss (17)
Women's health (12)
Worklife (5)
Date
Today (72)
Last 7 days (358)
Last 30 days (1224)
Last 365 days (14947)
2025 (3715)
2024 (15137)
2023 (13497)
2022 (16686)
2021 (17835)
2020 (16972)
2019 (14831)
2018 (11090)
2017 (11659)
2016 (10737)
2015 (11869)
2014 (8573)
2013 (7039)
2012 (7230)
2011 (7490)
2010 (6575)
Location
Africa (294)
Alabama (31)
Alaska (4)
Arizona (56)
Arkansas (3)
Asia (13831)
Australia (2780)
California (2434)
Canada (731)
China (157)
Colorado (128)
Connecticut (150)
Delaware (79)
Europe (27202)
Florida (385)
Georgia (103)
Idaho (13)
Illinois (230)
India (11)
Indiana (119)
Iowa (6)
Japan (76)
Kansas (27)
Kentucky (12)
Louisiana (2)
Maine (9)
Maryland (309)
Massachusetts (1950)
Michigan (71)
Minnesota (127)
Missouri (37)
Montana (14)
Nebraska (10)
Nevada (15)
New Hampshire (19)
New Jersey (819)
New Mexico (7)
New York (667)
North Carolina (282)
North Dakota (3)
Northern California (1052)
Ohio (77)
Oklahoma (5)
Oregon (10)
Pennsylvania (574)
Puerto Rico (1)
Rhode Island (13)
South America (390)
South Carolina (6)
Southern California (1009)
Tennessee (29)
Texas (389)
Utah (67)
Virginia (38)
Washington D.C. (38)
Washington State (224)
West Virginia (1)
Wisconsin (27)
210,456 Results for "biomed x institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioMed X Launches New US Institute in New Haven, CT
Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.
June 13, 2024
·
3 min read
Biotech Bay
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders.
May 28, 2024
·
3 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Job Trends
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany.
April 30, 2024
·
2 min read
Business
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
BioMed X announced a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research institute and one of the largest pharmaceutical companies in Japan.
December 19, 2023
·
3 min read
Business
BioMed X and AbbVie Start New Research Project in the USA
BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA.
October 31, 2023
·
3 min read
BioMed X Launches a New Call for Application in Autoimmune Disease Research
BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology.
November 7, 2023
·
2 min read
Press Releases
Harbour BioMed Reports Full Year 2024 Financial Results
April 1, 2025
·
14 min read
Call for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X
Ono Pharmaceutical Co., Ltd. informed that it has started a new collaboration with BioMed X on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.
January 9, 2024
·
1 min read
Press Releases
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
April 2, 2025
·
10 min read
1 of 21,046
Next
